IL1B and COVID-19: Increased serum levels of proinflammatory cytokines (TNF-α, IL-1, and IL-6) and chemokines (IL-8) have been found in patients with severe COVID-19, compared with individuals with mild disease, suggesting a possible role for a hyperinflammatory response in the pathogenesis of COVID-191,2.